Detalhe da pesquisa
1.
Apixaban Downregulates Endothelial Inflammatory and Prothrombotic Phenotype in an In Vitro Model of Endothelial Dysfunction in Uremia.
Cardiovasc Drugs Ther
; 35(3): 521-532, 2021 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-32651897
2.
Lithium Augmentation Versus Citalopram Combination in Imipramine-Resistant Major Depression: A 10-Week Randomized Open-Label Study.
J Clin Psychopharmacol
; 39(3): 254-257, 2019.
Artigo
em Inglês
| MEDLINE | ID: mdl-30925498
3.
Switching to Imipramine Versus Add-on Mirtazapine in Venlafaxine-Resistant Major Depression: A 10-Week Randomized Open Study.
J Clin Psychopharmacol
; 39(1): 63-66, 2019.
Artigo
em Inglês
| MEDLINE | ID: mdl-30516574
4.
Six-Week Outcome of 2-Week Antidepressant Nonimprovers in Severe Major Depression: A Prospective Naturalistic Single-Blind Study.
J Clin Psychopharmacol
; 39(4): 417-418, 2019.
Artigo
em Inglês
| MEDLINE | ID: mdl-31162153
5.
Antithrombotic and prohemorrhagic actions of different concentrations of apixaban in patients exposed to single and dual antiplatelet regimens.
Sci Rep
; 13(1): 22969, 2023 12 27.
Artigo
em Inglês
| MEDLINE | ID: mdl-38151494